等待开盘 10-18 09:30:00 美东时间
0.000
0.00%
HC Wainwright & Co. analyst Douglas Tsao reiterates Outlook Therapeutics (NASDAQ:OTLK) with a Neutral and maintains $1 price target.
09-30 19:41
Outlook Therapeutics ( ($OTLK) ) just unveiled an announcement. On September 29...
09-30 05:33
Ascendiant Capital analyst Edward Woo maintains Outlook Therapeutics (NASDAQ:OTLK) with a Buy and lowers the price target from $21 to $8.
09-22 17:30
Outlook Therapeutics ( ($OTLK) ) has provided an announcement. On September 5, ...
09-06 05:33
Outlook Therapeutics ( ($OTLK) ) has issued an update. On August 28, 2025, Outl...
09-03 05:32
HC Wainwright & Co. analyst Douglas Tsao downgrades Outlook Therapeutics (NASDAQ:OTLK) from Buy to Neutral and announces $1 price target.
08-29 20:47
FDA issues Complete Response Letter (CRL) for resubmitted ONS-5010 BLAOutlook Therapeutics plans to work with FDA to address the Agency's issuesCompany to host a conference call and webcast today, August 28th at 8:30 AM
08-28 18:33
Shares of MongoDB, Inc. (NASDAQ:MDB) rose sharply in pre-market trading after t...
08-27 18:05
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts jus...
08-18 19:50
Outlook Therapeutics (OTLK) has disclosed a new risk, in the Capital Markets ca...
08-16 14:00